Fluticasone Propionate Multidose Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Inhaler
- Study Title
- Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
- Teva Identifier
- FSS-AS-30003 | 2016-003835-39
- ClinicalTrials.gov Identifier
- NCT02980133
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Fluticasone Propionate | Drug: Fluticasone Propionate/Salmeterol | Drug: Placebo MDPI
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child
- Age Range
- 4 Years to 11 Years
- Trial Duration
- December 28, 2016 - April 13, 2019
- Phase
- Phase 3
